ArticleInfectious diseases and therapy2016

Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial.

Peter Ferenci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.